## Abstract Seventyβone women with farβadvanced breast cancer resistant to standard chemotherapeutic agents were administered mitomycin C using an intermittent high dose schedule. One group consisted of 54 patients with measurable metastatic tumor; a second group consisted of 18 patients with nonme
Clinical experience with mitomycin C in large infrequent doses
β Scribed by Thomas E. Godfrey; David W. Wilbur
- Publisher
- John Wiley and Sons
- Year
- 1972
- Tongue
- English
- Weight
- 459 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ^13^C MRS was installed on a clinical scanner at 1.5βT in order to facilitate integrated MR examinations of human brain disorders. Using a simplified protocol, (1β^13^C) glucose and/or (1β^13^C) acetate were administered orally or by intravenous infusion. ^13^C spectra of diagnostic qua
Using a cohort of macroscopic curative resections of gastric cancer at stages 11, Ill, and IV, a randomized controlled trial was performed to clucidate the dose efficacy of intensive adjuvant cancer chemotherapy with mitomycin C. Between June 1983 and December 1986, 336 patients with gastric cancer
## Abstract We conducted a multicentered, retrospective review of clozapine's (CZP) effects on a range of psychiatric, sleep, cognitive, motor, and sensory disorders in Parkinson's disease (PD). Therapeutic outcomes and adverse events were compared with varying prescribing practices at participatin
## Abstract Nine evaluable patients with refractory solid tumors received mitomycin C as a single intravenous injection at a dose of 20 mg/m^2^ at 6β to 8βweek intervals. Toxicity was tolerable. One patient with Wilms'tumor had a transient decrease in liver size. Pharmacokinetic data on three patie